Brief: T2 Biosystems Announces Third Quarter 2022 Financial Results
10/11/2022 21:35
Nov 10 (Reuters) - T2 Biosystems Inc TTOO.O :
* T2 BIOSYSTEMS ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS
* T2 BIOSYSTEMS INC Q3 REVENUE $3.7 MILLION
* T2 BIOSYSTEMS INC - QTRLY LOSS PER SHARE OF $2.95
* T2 BIOSYSTEMS INC - CASH, CASH EQUIVALENTS AND RESTRICTED
CASH
WERE $21.5 MILLION AS OF SEPTEMBER 30, 2022
* T2 BIOSYSTEMS INC - SEES FULL YEAR 2022 TOTAL REVENUE OF
$22.0
MILLION TO $23.0 MILLION
Source text for Eikon: ID:nGNX8dSXYQ
Further company coverage: TTOO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on T2 Biosystems
See all newsBrief: T2 Biosystems Announces Intent To Wind Down Operations
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor